147 related articles for article (PubMed ID: 27426302)
21. 4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
Olsson H; Sjö P; Ersoy O; Kristoffersson A; Larsson J; Nordén B
Bioorg Med Chem Lett; 2010 Aug; 20(16):4738-40. PubMed ID: 20643547
[TBL] [Abstract][Full Text] [Related]
22. Discovery and Characterization of a Biologically Active Non-ATP-Competitive p38 MAP Kinase Inhibitor.
Wilson BA; Alam MS; Guszczynski T; Jakob M; Shenoy SR; Mitchell CA; Goncharova EI; Evans JR; Wipf P; Liu G; Ashwell JD; O'Keefe BR
J Biomol Screen; 2016 Mar; 21(3):277-89. PubMed ID: 26538432
[TBL] [Abstract][Full Text] [Related]
23. Screening and identification of a novel class of TGF-β type 1 receptor kinase inhibitor.
Huynh QK; Wise SJ; Koch KA; Castonguay LA; Reid BG; Pagratis EE; Koditek D; Glascock CB; Pitts KR; Turner BA; Liu X; Hung M; Han B; Pagratis N
J Biomol Screen; 2011 Aug; 16(7):724-33. PubMed ID: 21521800
[TBL] [Abstract][Full Text] [Related]
24. SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors.
Heron NM; Anderson M; Blowers DP; Breed J; Eden JM; Green S; Hill GB; Johnson T; Jung FH; McMiken HH; Mortlock AA; Pannifer AD; Pauptit RA; Pink J; Roberts NJ; Rowsell S
Bioorg Med Chem Lett; 2006 Mar; 16(5):1320-3. PubMed ID: 16337122
[TBL] [Abstract][Full Text] [Related]
25. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
Simard JR; Rauh D
Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
[TBL] [Abstract][Full Text] [Related]
27. High-throughput Docking and Molecular Dynamics Simulations towards the Identification of Novel Peptidomimetic Inhibitors against CDC7.
Makhouri FR; Ghasemi JB
Mol Inform; 2018 Nov; 37(11):e1800022. PubMed ID: 29984527
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors.
Heo J; Shin H; Lee J; Kim T; Inn KS; Kim NJ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3694-8. PubMed ID: 26115577
[TBL] [Abstract][Full Text] [Related]
29. Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activity.
Sharlow ER; Mustata Wilson G; Close D; Leimgruber S; Tandon M; Reed RB; Shun TY; Wang QJ; Wipf P; Lazo JS
PLoS One; 2011; 6(10):e25134. PubMed ID: 21998636
[TBL] [Abstract][Full Text] [Related]
30. Discovery of Diverse Small-Molecule Inhibitors of Mammalian Sterile20-like Kinase 3 (MST3).
Olesen SH; Zhu JY; Martin MP; Schönbrunn E
ChemMedChem; 2016 Jun; 11(11):1137-44. PubMed ID: 27135311
[TBL] [Abstract][Full Text] [Related]
31. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
Chuaqui C; Deng Z; Singh J
J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
[TBL] [Abstract][Full Text] [Related]
32. Probing 2H-Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors.
Schoene J; Gazzi T; Lindemann P; Christmann M; Volkamer A; Nazaré M
ChemMedChem; 2019 Aug; 14(16):1514-1527. PubMed ID: 31264364
[TBL] [Abstract][Full Text] [Related]
33. Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4.
Powers JP; Li S; Jaen JC; Liu J; Walker NP; Wang Z; Wesche H
Bioorg Med Chem Lett; 2006 Jun; 16(11):2842-5. PubMed ID: 16563752
[TBL] [Abstract][Full Text] [Related]
34. Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships.
Asquith CRM; Laitinen T; Bennett JM; Wells CI; Elkins JM; Zuercher WJ; Tizzard GJ; Poso A
ChemMedChem; 2020 Jan; 15(1):26-49. PubMed ID: 31675459
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in development of hetero-bivalent kinase inhibitors.
Lee S; Kim J; Jo J; Chang JW; Sim J; Yun H
Eur J Med Chem; 2021 Apr; 216():113318. PubMed ID: 33730624
[TBL] [Abstract][Full Text] [Related]
36. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
37. Cell-Based High-Throughput Luciferase Reporter Gene Assays for Identifying and Profiling Chemical Modulators of Endoplasmic Reticulum Signaling Protein, IRE1.
Rong J; Pass I; Diaz PW; Ngo TA; Sauer M; Magnuson G; Zeng FY; Hassig CA; Jackson MR; Cosford ND; Matsuzawa S; Reed JC
J Biomol Screen; 2015 Dec; 20(10):1232-45. PubMed ID: 26265713
[TBL] [Abstract][Full Text] [Related]
38. Identification of a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A.
Schröder D; Rehbach C; Seyffarth C; Neuenschwander M; Kries JV; Windhorst S
Biochem Biophys Res Commun; 2013 Sep; 439(2):228-34. PubMed ID: 23981806
[TBL] [Abstract][Full Text] [Related]
39. Sequence, structure, and active site analyses of p38 MAP kinase: exploiting DFG-out conformation as a strategy to design new type II leads.
Badrinarayan P; Sastry GN
J Chem Inf Model; 2011 Jan; 51(1):115-29. PubMed ID: 21141877
[TBL] [Abstract][Full Text] [Related]
40. Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis.
Andrews MJ; Clase JA; Bar G; Tricarico G; Edwards PJ; Brys R; Chambers M; Schmidt W; MacLeod A; Hirst K; Allen V; Birault V; Le J; Harris J; Self A; Nash K; Dixon G
Bioorg Med Chem Lett; 2012 Mar; 22(6):2266-70. PubMed ID: 22342143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
